Description | A Transcriptome Fingerprinting Assay for Clinical Immune Monitoring (Sepsis Datasets) - GSE100159 |
Purpose | Development of a cost-effective and practical targeted transcriptional fingerprinting assay (TFA) for monitoring a diverse repertoire of immune responses identified in the human blood transcriptome relying on a modular transcriptional repertoire built on the basis of variations in transcript abundance measured on a genome wide scale in the blood of nearly 1000 subjects across 16 immunologic conditions. |
Experimental Design | Sepsis (35 condition, 12 control, 47 total) |
Experimental Variables | Septicemic Melioidosis (2021 ICD-10-CM code* = A24.1) |
Methods | The data were normalised using average normalization with Genome Studio |
Additional Information | https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE100159 |
Platform | Illumina HumanWG-6 v3 |
(Uploaded through the Files tab in the Annotation Tool)
|